Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : NZ$6.19 Billion

According to Galapagos NV's latest financial reports the company has NZ$6.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$5.75 B-10.69%
2023-12-31NZ$6.44 B-6.89%
2022-12-31NZ$6.91 B-11.3%
2021-12-31NZ$7.79 B-11.37%
2020-12-31NZ$8.79 B-8.5%
2019-12-31NZ$9.61 B336.78%
2018-12-31NZ$2.20 B13.19%
2017-12-31NZ$1.94 B31.6%
2016-12-31NZ$1.47 B171.83%
2015-12-31NZ$0.54 B86.59%
2014-12-31NZ$0.29 B25.48%
2013-12-31NZ$0.23 B52.58%
2012-12-31NZ$0.15 B180.94%
2011-12-31NZ$54.17 M-22.22%
2010-12-31NZ$69.64 M-25.49%
2009-12-31NZ$93.48 M42.06%
2008-12-31NZ$65.8 M-29.97%
2007-12-31NZ$93.96 M-2.62%
2006-12-31NZ$96.49 M135.74%
2005-12-31NZ$40.93 M109.57%
2004-12-31NZ$19.53 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
NZ$14.16 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$32.13 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$18.09 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$9.81 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$0.12 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.81 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$7.69 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$31.52 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA